Related Experiment Video
Updated: Feb 6, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Anaplastic lymphoma kinase: activating mechanisms and signaling pathways
Marco Pizzi1, Marcello Gaudiano, Maria Todaro2
1Department of Medicine, DIMED, General Pathology,Cytopathology Unit, University of Padova, Padova, Italy.
Abstract:
The discovery of Anaplastic Lymphoma Kinase (ALK) by Stephan Morris and colleagues twenty years ago has led to an unprecedented opportunity and provided the basis for a novel and clinically powerful stratification of human cancers. The molecular and biological characterization of ALK and the recognition of alternative mechanisms of activation of the tyrosine kinase receptors have then set the basis for the development and the subsequent application of selective small molecules. These achievements have fostered a new era in oncology, and the result of this new avenue has drastically changed the expectation of many cancer patients. Here we review the mechanisms of ALK activation and the modalities that drive ALK pathogenesis.
Insights
The discovery of Anaplastic Lymphoma Kinase (ALK) offers new cancer treatments. Understanding ALK activation mechanisms drives targeted therapies, improving patient outcomes in oncology.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The discovery of Anaplastic Lymphoma Kinase (ALK) has revolutionized cancer stratification.
- Understanding ALK's role is crucial for developing targeted therapies.
Purpose of the Study:
- To review the mechanisms of ALK activation.
- To explore the pathways driving ALK-driven cancer pathogenesis.
Main Methods:
- Literature review of ALK discovery and characterization.
- Analysis of molecular and biological data on tyrosine kinase receptor activation.
- Review of clinical applications of selective small molecules targeting ALK.
Main Results:
- ALK discovery enabled novel cancer stratification.
- Characterization of ALK and its activation pathways.
- Development of targeted therapies has changed cancer patient expectations.
Conclusions:
- ALK activation mechanisms are key to understanding cancer.
- Targeted therapies based on ALK alterations represent a significant advancement in oncology.
- Further research into ALK pathogenesis can lead to improved treatment strategies.
More Related Videos
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
07:16Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
cAMP-dependent Protein Kinase Pathways
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Non-Canonical Wnt Signaling Pathways